Cargando…
Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects
We recently identified acyl coenzyme A-binding protein (ACBP)/diazepam binding inhibitor (DBI) as a novel ‘hunger factor’: a protein that is upregulated in human or murine obesity and that, if administered to mice, causes hyperphagy, adipogenesis and obesity. Conversely, neutralization of ACBP/DBI b...
Autores principales: | Sica, Valentina, Martins, Isabelle, Motiño, Omar, Bravo-San Pedro, José M., Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153538/ https://www.ncbi.nlm.nih.gov/pubmed/32157940 http://dx.doi.org/10.1080/21623945.2020.1736734 |
Ejemplares similares
-
Elevated plasma levels of the appetite-stimulator ACBP/DBI in fasting and obese subjects
por: Li, Sijing, et al.
Publicado: (2021) -
Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin
por: Montégut, Léa, et al.
Publicado: (2022) -
ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis
por: Motiño, Omar, et al.
Publicado: (2022) -
DBI/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease
por: Montégut, Léa, et al.
Publicado: (2022) -
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
por: Joseph, Adrien, et al.
Publicado: (2021)